News from european hematology association (eha) A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

28 Aug, 2020, 13:39 BST European Hematology Association launching new European Immunotherapy Net website

European Immunotherapy Net [immunotherapy.ehaweb.org] is a new platform that brings the latest news and updates in all areas of immunotherapy...


13 Jun, 2020, 07:30 BST EHA25Virtual: A Paradigm Shift for the Treatment of Newly Diagnosed Older Acute Myeloid Leukemia Patients

Acute myeloid leukemia (AML) is primarily a disease of older adults. Standard commonly utilized lower-intensity therapies, such as azacitidine or...


13 Jun, 2020, 07:30 BST EHA25Virtual: Study of Subcutaneous Daratumumab Shows Improved Clinical Outcomes in the Treatment of Patients with Amyloidosis

Light chain (AL) amyloidosis is a rare and potentially fatal multi-system disorder that occurs when bone marrow produces abnormal pieces of...


13 Jun, 2020, 07:30 BST EHA25Virtual: Adult Patients With Sickle Cell Disease May Be at Increased Risk of Adverse Outcomes From COVID-19

Sickle cell disease (SCD) and thalassemia are severe inherited blood disorders, often referred to as "hemoglobinopathies." They predominantly affect...


12 Jun, 2020, 07:30 BST EHA25Virtual: Promising Treatment Results with Imetelstat, a Novel Telomerase Inhibitor, in Patients with Lower Risk Myelodysplastic Syndromes

IMerge is a Phase 2/3 clinical trial evaluating imetelstat as a treatment for patients with lower risk myelodysplastic syndromes (MDS)that are...


12 Jun, 2020, 07:30 BST EHA25Virtual: Combined Irradiation and Chemotherapy Better Prepares Children for Stem Cell Transplantation than Chemotherapy Alone

Treatment of childhood cancer is a success story, particularly for acute lymphoblastic leukemia (ALL). More than 90% of ALL patients below 18 years...


12 Jun, 2020, 07:30 BST EHA25Virtual: A New Paradigm in Relapsed Refractory Hodgkin Lymphoma

Patients with relapsed/refractory classical Hodgkin lymphoma (R/R cHL) have few treatment options when they are ineligible for autologous stem-cell...


12 Jun, 2020, 07:30 BST EHA25Virtual: Ruxolitinib, the First Proven Drug for Treating Steroid-refractory Acute GVHD

Acute graft-versus-host disease (GVHD) remains a major limitation of allogeneic stem-cell transplantation; not all patients respond to standard...


12 Jun, 2020, 07:30 BST EHA25Virtual: A Safe and Strikingly Effective Biologic Therapy for the World's Second Most Common Hereditary Bleeding Disorder

With a prevalence of 1 in 5000, hereditary hemorrhagic telangiectasia (HHT, Osler-Weber-Rendu disease) is the second most common hereditary bleeding...


12 Jun, 2020, 07:30 BST EHA25Virtual: Advances in Treatment of High Risk Chronic Lymphocytic Leukemia

Prognosis in high risk Chronic Lymphocytic Leukemia (CLL) is still unsatisfactory. Despite the availability of novel pharmaceutical agents (alone or...


12 Jun, 2020, 07:30 BST EHA25Virtual: Pegcetacoplan, a Novel C3 Complement Inhibitor - Beginning of a new era in the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

PNH is a rare but severe and usually life-long blood disease in which the blood cells are fragile and easily destroyed by a part of the patient's own ...


12 Jun, 2020, 07:30 BST EHA25Virtual: PET-guided Therapy Allows Omission of Radiotherapy in Early-stage Unfavorable Hodgkin Lymphoma

For decades, combined modality treatment (CMT) comprising of four cycles of chemotherapy and radiotherapy has been the standard of care in...


12 Jun, 2020, 07:30 BST EHA25Virtual: Gut Microbiome Disturbance by Antibiotic Treatment Early in Life is Sufficient to Induce Leukemia in Predisposed Mice

Genetic predisposition to childhood leukemia is frequent (>1-5%), but less than 1% of genetic carriers will actually develop the disease. Infectious...


09 Jun, 2020, 07:00 BST 25th Congress of the European Hematology Association (EHA): The First Ever Virtual Edition

EHA is organizing a virtual congress for the first time in its history. Due to the COVID-19 pandemic and social distancing restrictions, it is no...


03 Dec, 2018, 07:30 GMT EHA and EBMT Joint Meeting on CAR T Cells, First of its Kind in Europe

The European Hematology Association (EHA) and European Society for Blood and Marrow Transplantation (EBMT) will hold the first European CAR T Cell...


21 Dec, 2017, 10:04 GMT First Publication of HemaSphere, the New Journal of the European Hematology Association, Now Online

HemaSphere, the new open access journal of the European Hematology Association (EHA),was published on December 20. (Logo:...